Craft

Singular Genomics

Stock Price

$0.4

2024-01-23

Market Capitalization

$29.7 M

2024-01-23

Revenue

$765 K

FY, 2022

Singular Genomics Summary

Company Summary

Overview
Singular Genomics Systems is a life science technology company that develops next-generation sequencing (NGS) and multi-omics technologies to build products for researchers and clinicians. It focuses on nucleotides, linkers, and fluorescent dyes synthesis.
Type
Public
Status
Active
Founded
2016
HQ
San Diego, CA, US | view all locations
Website
https://singulargenomics.com/
Cybersecurity rating
Sectors

Key People

  • Andrew Spaventa
  • Eli Glezer
  • Jorge Velarde

    Jorge Velarde, Senior Vice President of Corporate Development & Strategy

  • Daralyn Durie

    Daralyn Durie, General Counsel

    Operating MetricsView all

    Facility Space Leased, sq. ft.

    83.5K

    FY, 2021

    LocationsView all

    1 location detected

    • San Diego, CA HQ

      United States

      3010 Science Park Rd

    Singular Genomics Financials

    Summary Financials

    Revenue (Q3, 2023)
    $462.0K
    Gross profit (Q3, 2023)
    ($65.0K)
    Net income (Q3, 2023)
    ($22.4M)
    Cash (Q3, 2023)
    $33.3M
    EBIT (Q3, 2023)
    ($24.5M)
    Enterprise value
    $14.3M

    Footer menu